Bluebird bio, Inc.
BLUE
Xếp hạng trong cổ phiếu
#15560
bluebird bio, Inc. is a biotechnology firm that concentrates on the discovery,... bluebird bio, Inc. is a biotechnology firm that concentrates on the discovery, development, and commercialization of innovative gene therapies. These pioneering treatments are aimed at debilitating genetic conditions. Among its leading investigational therapies for severe inherited diseases are betibeglogene autotemcel (beti-cel), intended for patients with transfusion-dependent beta-thalassemia; lovotibeglogene autotemcel (lovo-cel), which targets sickle cell disease (SCD); and elivaldogene autotemcel (eli-cel), developed to address cerebral adrenoleukodystrophy. The company's robust clinical trial program is actively evaluating the safety and efficacy of these treatments. Specifically, lovo-cel's impact on SCD patients is being assessed in studies HGB-205, HGB-206, and HGB-210. Concurrently, beti-cel is under investigation for beta-thalassemia in trials HGB-204, HGB-205, HGB-207, and HGB-212. Furthermore, bluebird bio maintains strategic collaborations and licensing arrangements with entities such as Orchard Therapeutics Limited, Forty Seven, Inc., and Magenta Therapeutics, Inc. The company, which began its operations in 1992, was formerly known as Genetix Pharmaceuticals, Inc., and rebranded as bluebird bio, Inc. in September 2010. Its principal office is located in Cambridge, Massachusetts.
Giá cổ phiếu
$4.97
Đồng bộ lần cuối: 2025-06-02
Vốn hóa thị trường
$318.62M
Thay đổi (1 ngày)
0.00%
Thay đổi (1 năm)
-38.03%
Quốc gia
US
Giao dịch Bluebird bio, Inc. (BLUE)
Danh mục
Healthcare
Lịch sử giá cổ phiếu của Bluebird bio, Inc. (BLUE)
Giá đóng cửa cao nhất: $8.24 vào 2025-01-01
Giá đóng cửa thấp nhất: $1.93K vào 2018-01-01
Giá đóng cửa thấp nhất: $1.93K vào 2018-01-01
Lịch sử giá cổ phiếu của Bluebird bio, Inc. từ 2018 đến 2026
Hiệu suất giá cổ phiếu hàng năm
| Năm | Hiệu suất |
|---|---|
| 2025 | -0.01% |
| 2024 | -86.21% |
| 2023 | -60.75% |
| 2022 | -23.07% |
| 2021 | -59.15% |
| 2020 | -57.22% |
| 2019 | -15.48% |
| 2018 | 0.00% |
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
| Công ty | Giá cổ phiếu | Thay đổi 1năm% | Quốc gia |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
